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Abstract
Glycoprotein	hormone	receptors	(provisional	nomenclature	[45])	are	activated	by	a	non-covalent
heterodimeric	glycoprotein	made	up	of	a	common	α	chain	(glycoprotein	hormone	common	alpha	subunit	CGA,
P01215),	with	a	unique	β	chain	that	confers	the	biological	specificity	to	FSH,	LH,	hCG	or	TSH.	There	is	binding
cross-reactivity	across	the	endogenous	agonists	for	each	of	the	glycoprotein	hormone	receptors.	The
deglycosylated	hormones	appear	to	exhibit	reduced	efficacy	at	these	receptors	[120].
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